| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.24 | 2e-06 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.15 | 0.003 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.14 | 0.009 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.13 | 0.04 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.11 | 0.05 |